The global isocitrate dehydrogenase (IDH) inhibitors market is poised for extraordinary growth, with a market value of USD 2.26 billion in 2023 projected to surge to a staggering USD 39.16 billion by 2033, marking a robust compound annual growth rate (CAGR) of 33% over the forecast period. Additionally, the development of more potent and selective …
Category Archives: Healthcare Trends
Global Lumbosacral Radicular Pain Management Market Poised for Robust Growth, Expected to Reach USD 1.4 Billion by 2033: FMI Study
The global lumbosacral radicular pain management market is set to witness significant growth, reaching a valuation of USD 1.4 billion by 2033. This represents a steady CAGR of 5% during the forecast period from 2023 to 2033. In 2023, the market is projected to achieve a valuation of USD 0.9 billion, showcasing the sector’s growing …
Molecular Diagnostics Market Poised for Steady Growth USD 60,347.40 Million by 2034 at a 4.30% of CAGR, Driven by Increasing Disease Prevalence and Aging Population
The global molecular diagnostics market is projected to experience steady growth over the next decade, driven by the rising prevalence of chronic and contagious diseases, as well as an aging global population. According to current market projections, the market is expected to reach US$ 60,347.40 million by 2034, climbing from US$ 39,611.00 million in 2024. …
Bioprocess Validation Market to Witness Steady Growth USD 996.29 Million at a 9.20% of CAGR
The global bioprocess validation market is on a path of significant expansion, fueled by rising demand for biopharmaceutical production and stringent regulatory requirements. According to recent market research conducted by FMI, the bioprocess validation market is expected to grow at a compound annual growth rate (CAGR) of 9.20% from 2023 to 2033. With a projected …
Ablation Devices Market Set for Robust Growth USD 12.6 Billion by 2033 at a 11.1% of CAGR
The global ablation devices market is poised for substantial growth, driven by rising demand for minimally invasive surgical solutions and advancements in medical technology. Valued at US$ 4.4 billion in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 11.1%, reaching an impressive US$ 12.6 billion by 2033. The …
RNA-Targeted Small Molecules Market to Experience Steady Growth USD 4,311.7 Million by 2034 at a 6.3% of CAGR, Driven by Advancements in Genetic Therapy
The global RNA-targeted small molecules market is on a trajectory of steady growth, reflecting its transformative potential in genetic and chronic disease treatments. Valued at USD 2,308.1 million in 2023, the market is expected to reach USD 2,453.5 million in 2024 and expand at a compound annual growth rate (CAGR) of 6.3% through 2034. By …
Injectable Drug Delivery Market Poised for Significant Growth USD 113.87 Billion by 2034 at a 8.70% of CAGR, Amid Rising Demand for Advanced Treatment Solutions
The global injectable drug delivery market is undergoing substantial growth, fueled by advancements in medical technology and the rising prevalence of life-threatening and chronic diseases. Valued at US$ 49.44 billion in 2024, the market is set to expand at a healthy compound annual growth rate (CAGR) of 8.70% through 2034. By the end of this …
Image-Guided Radiotherapy Market Set for Strong Growth USD 7.4 billion by 2034 at a 14.7% of CAGR, Amid Rising Cancer Incidence
The global image-guided radiotherapy (IGRT) market is poised for significant expansion, reflecting the rising global burden of cancer and rapid advancements in treatment technologies. The market is projected to reach US$ 1.9 billion in 2024, driven by growing demand for advanced cancer treatment modalities. Over the forecast period from 2024 to 2034, the market is …
Legionella Testing Market Poised for Robust Growth USD 910 Million by 2034 at a 9.9% of CAGR Amid Rising Health Concerns
The global legionella testing market is set to witness significant expansion, driven by growing public health awareness and the increasing prevalence of Legionella-related diseases. Valued at US$ 355.1 million in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 9.9% over the next decade, surpassing US$ 910 million by …
Flow Cytometry Market on Steady Growth Projected Size USD 12,661.7 Million by 2034 at a 7.1% of CAGR
The global flow cytometry market is set to achieve robust growth, reflecting its critical role in both research and clinical applications. The market revenue, valued at USD 5,985.8 million in 2023, is anticipated to reach USD 6,376.7 million in 2024, showcasing a year-on-year (Y-o-Y) growth of 7.2%. Over the next decade, the industry is projected …